Steryl is raising its founding investment round. This is ground-floor access to the platform that will process billions of dollars in healthcare procurement across the continent.
$6B+
Total Market
Live
Platform Status
3
Revenue Streams
5
Org Types
Real metrics from a live, operational platform — not projections, not mockups. Steryl is running today.
0
Hospitals Onboarded
Registered & approved
0
Pharmacies Onboarded
Active on platform
0
Manufacturers
Verified & listed
0
Orders Processed
Since beta launch
0
Inventory Items
Tracked
₦4.1M
Monthly Recurring
Revenue
0
Active Users
This Month
0
Country
Nigeria
0
Strategic
Partnerships
+38%
Revenue Growth
MoM
Organisations joined per month
Cumulative onboarding since beta launch
M1
M2
M3
M4
M5
M6
M7
Target
Target
Choose the structure that fits your risk profile — maximum upside or stable income. Both tiers invest in the same platform.
Tier 1
Maximum equity. Maximum upside. For bold investors who see the vision early.
₦25,000
/share
Minimum: 10 shares (₦250,000)
Projected 3-year return: 2.5×–4× (Base scenario)
Tier 2
Steady income preference. Lower risk profile. Ideal for institutional or conservative investors.
₦15,000
/share
Minimum: 20 shares (₦300,000)
Target annual yield: 15% per annum
Every transaction, subscription and integration that flows through Steryl generates revenue. Ten distinct streams compound together — the platform earns whether clients are ordering, reporting, financing or scaling.
SaaS Subscriptions
Monthly / annual platform access fee per organisation. Tiered by size and feature set.
₦15k–₦120k/mo
Procurement Fees
Per-order transaction fee (1.5–3%) on every purchase order matched through the platform.
1.5% – 3% per order
Logistics Commissions
Commission on every shipment facilitated through Steryl's logistics network and partners.
2% per shipment
Premium Analytics
Advanced reporting, demand forecasting, and spending intelligence as a paid add-on tier.
₦25k–₦80k/mo
API Licensing
External systems (EMRs, ERP, government portals) pay to integrate via the Steryl data API.
Usage-based pricing
Financing Commissions
Earn referral commission when facilities access supply credit or invoice financing through Steryl partners.
3% – 5% per deal
Marketplace Fees
Manufacturers pay listing and placement fees to feature products prominently in the Steryl catalogue.
₦10k – ₦50k/mo
Enterprise Contracts
Custom annual agreements with large hospital chains, multi-location labs, and pharmacy retail groups.
₦2M – ₦8M/yr
Government Licensing
State and federal health agencies pay for access to aggregated, anonymised supply chain intelligence.
Annual licence fee
White-Label Platform
Other African markets can deploy Steryl under their own brand — licensed as a fully managed SaaS.
Revenue share + setup
Revenue Sources
Distribution
60%
Operations & Growth
Tech, sales, team, expansion
25%
Shareholder Returns
Dividends + capital appreciation
15%
R&D Reserve
New markets, AI features
₦4.1M
Current MRR
₦18M+
Projected MRR (12 mo)
₦216M+
Projected ARR (Yr 1)
Every organisation on the platform generates revenue. As the network grows, revenue compounds — this is the economics of a marketplace, not a SaaS tool.
Stream 1
Every registered organisation pays a monthly platform fee — hospitals, labs, pharmacies, manufacturers and distributors.
100 orgs × ₦25k avg = ₦2.5M/month
Stream 2
A small percentage on the total value of every order processed through the platform — scales automatically with order volume.
Transaction fee: 1.5% of order value
50 orgs × ₦2M avg monthly orders = ₦100M GMV
1.5% × ₦100M = ₦1.5M/month
Grows with every new order placed
Stream 3
Manufacturers pay for verified listing status, featured placement in the catalogue, and premium analytics on their product demand.
20 manufacturers = ₦2.1M/month
Conservative estimate — 80 orgs by month 12 at average ₦28,000/month subscription
Month 6 Total Revenue
₦4.2M
Month 12 Total Revenue
₦9.8M
Year 1 Cumulative
₦72M+
100%
Accounted for
Backend scaling, mobile app development, API integrations with logistics and banking partners, security audits.
Hospital and clinic onboarding team, manufacturer partnership development, marketing across Lagos, Abuja and Port Harcourt.
Customer support team, account management, infrastructure costs, distribution logistics support.
NAFDAC and regulatory licensing, data protection compliance (NDPR), contracts and intellectual property registration.
Close founding round. Public launch of platform. First 10 paying organisations onboarded. Distributor operations begin.
Expand to 50 paying orgs. Launch manufacturer verified listings. First quarterly dividend payment to Growth shareholders. Mobile app beta.
100 organisations active. Full mobile app launch. Expand to Abuja and Port Harcourt markets. First annual dividend for Founding shareholders.
Series A fundraise at higher valuation. Founding shareholders see equity appreciation. Expansion to Ghana, Kenya and Rwanda. Founding share value targets 2.5×+ original.
Three forces are converging that make 2026 the optimal entry point.
Nigeria's smartphone adoption passed 60% in 2025. Healthcare administrators are now comfortable running operations digitally — the behaviour shift already happened.
The National Health Insurance Authority's 2026 mandate requires digital procurement records from all accredited facilities. Steryl is that digital record system.
No end-to-end African healthcare supply chain platform owns this space yet. The window to establish first-mover advantage is open — but not for long.
Is this a public share offering?
No. This is a private placement round for qualified investors. Shares are not listed on any exchange. A shareholders' agreement governs the terms. We recommend consulting your financial adviser before committing.
When will I start receiving dividends?
Growth shareholders receive quarterly distributions beginning Q4 2026 (Month 6 post-launch), assuming revenue targets are met. Founding shareholder dividends begin Q1 2027 from annual net profits.
Can I exit my investment?
Growth shares include a buyback provision after 24 months at a pre-agreed formula. Founding shares can be transferred to another investor with company approval. A secondary market may be established after the Series A round.
What happens if revenue targets are not met?
As with any early-stage investment, returns are not guaranteed. Growth share dividends are "targeted" not contractually guaranteed. Founding shares carry higher risk for higher potential upside. Investors should treat this as risk capital and diversify accordingly.
Is the platform actually built and working?
Yes. The platform is fully functional and operational today. You can watch live demos, register a test organisation, and speak to the founders for a walkthrough. There is no vaporware risk here — you are investing in a working product seeking distribution, not an idea.
What is the minimum investment?
Founding shares: ₦250,000 (10 shares at ₦25,000 each). Growth shares: ₦300,000 (20 shares at ₦15,000 each). Investors may hold shares in both tiers.
Submit this form and our team will contact you within 48 hours with the full investment pack, shareholder agreement preview, and next steps.
Our investment team will reach you within 48 hours. Please also check your email for our investment information pack.